Marshall Wace North America’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
EC
PAI
FLAM
RG
Marshall Wace North America's PRTA Position: Q3 2021 in Review
Marshall Wace North America opened a new position in Prothena Corp (PRTA) in Q3 2021: 34,755 shares worth $2.47M. The stake represents 0.01% of the portfolio and ranks #678 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in PRTA as recently as Q1 2021.
Marshall Wace North America first reported a position in PRTA in Q1 2017 and has held it in 7 quarters since. The position peaked at $7.31M in Q1 2018. 192 funds tracked by Wall St. Rank hold PRTA as of Q3 2021.
- Marshall Wace North America held 34,755 shares of Prothena Corp worth $2.47M as of Q3 2021.
- Prothena Corp was a new Marshall Wace North America position in Q3 2021.
- Prothena Corp made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #678 holding.
- Marshall Wace North America first reported a position in Prothena Corp in Q1 2017 and has held it in 7 quarters since.
- Marshall Wace North America's Prothena Corp position peaked at $7.31M in Q1 2018.
- 192 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2021.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.